What's Happening

Indicated for the treatment of spasticity resulting from multiple sclerosis, as well as in patients with spinal cord injuries or diseases.

Indicated for the treatment of Hepatitis C genotypes 1-4 in patients without cirrhosis, or with compensated cirrhosis as part of a combination antiviral treatment regimen.

Indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Indicated to reduce the risk of HIV-1 infection

Indicated to improve glycemic control for type 1 and 2 diabetes

The 7th biosimilar approved for adalimumab. For the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s Disease, ulcerative colitis, and plaque psoriasis

Indicated for the treatment of seizures, and for the preventive treatment of migraine

Indicated for the treatment of opioid-induced constipation

Indicated for the emergency treatment of known or suspected opioid overdose

A combination opioid agonist and NSAID indicated for the management of acute pain severe enough to require an opioid and for which alternative treatments are inadequate